Who Can Participate?
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Compensation
No
Spanish Materials Available
No
Study Details
Full Title
Expanded Access Program to Treat Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma with Daraxonrasib
Principal Investigator
Niharika
Mettu
Protocol Number
PRO00120510
NCT ID
NA
Phase
N/A
Enrollment Status
Open to Enrollment